病原体对呼吸系统疾病的影响

鹏 张(内蒙古医科大学，中国)
春梅 云(内蒙古自治区人民医院，中国)
玲 周(北戴河康复疗养中心，中国)

摘要

慢性气道疾病包括广泛的上、下气道疾病，如鼻炎、慢性鼻-鼻窦炎、支气管炎、肺炎，这些疾病经常同时发生，因为它们可以代表单一潜在病理生物学过程的不同表现。呼吸道感染是人类最常见的传染病，一般来说，上呼吸道病毒感染会导致轻微的自限症状，然而，更严重的下呼吸道感染可导致肺炎的发展。

关键词

呼吸系统疾病；细菌；病毒

参考

Watson K, Carville K, Bowman J, et al. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia[J]. Pediatric Infectious Disease Journal, 2006,25(9):782-790.

Guthrie R. Community-Acquired Lower Respiratory Tract Infections: Etiology and Treatment - ScienceDirect[J]. Chest, 2001,120(6):2021-2034.

Savolainen S, Ylikoski J S, Jousimies-Somer H. The bacterial flora of the nasal cavity in healthy young men[J]. Rhinology, 1986,24(4):249-255.

Brook, Itzhak. The Role of Bacteria in Chronic Rhinosinusitis[J]. Otolaryngologic Clinics of North America, 2005,38(6):1171-1192.

Wald E. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor[J]. J Pediatr, 1984,104.

Kusano K, Inokuchi A, Fujimoto K, et al. Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy[J]. Journal of Gastroenterology, 2010,45(4):406-412.

N Siupsinskiene, Katutiene I, Jonikiene V, et al. IntranasalHelicobacter pylori infection in patients with chronic rhinosinusitis with polyposis[J]. The Journal of Laryngology & Otology, 2018,132:1-6.

Low D E. Nonpneumococcal StreptoCOccal Infections, Rheumatic Fever[J]. Goldman’s Cecil Medicine (Twenty-Fourth Edition), 2011.

Pichichero M E. Group A Streptococcal Tonsillopharyngitis: Cost-Effective Diagnosis and Treatment[J]. Annals of Emergency Medicine, 1995,25(3):390-403.

Gottlieb M, Long B, Koyfman A. Clinical Mimics: An Emergency Medicine-Focused Review of Streptococcal Pharyngitis Mimics[J]. Journal of Emergency Medicine, 2018:S073646791830043X.

Gonzales, Ralph, Bartlett, et al. Principles of Appropriate Antibiotic Use for Treatment of Uncomplicated Acute Bronchitis: Background[J]. Annals of Emergency Medicine, 2001,37(6):720-727.

Kohei H, Tuomas J, Mansbach J M, et al. Respiratory Syncytial Virus Genomic Load and Disease Severity Among Children Hospitalized With Bronchiolitis: Multicenter Cohort Studies in the United States and Finland[J]. Journal of Infectious Diseases, 2015(10):1550-1559.

Piedimonte G, Perez M K. Respiratory syncytial virus infection and bronchiolitis[J]. Pediatrics in Review, 2014,35(12):519-530.

Jonathan, M, Mansbach, et al. Prospective Multicenter Study of the Viral Etiology of Bronchiolitis in the Emergency Department[J]. Academic Emergency Medicine, 2008.

Britt H, Miller G C, Knox S, et al. General practice activity in Australia 2003–04[J]. Canberra: Australian Institute of Health and Welfare, 2004.

Zhang X B, Wu X, Nong G M. Update on protracted bacterial bronchitis in children[J]. Italian Journal of Pediatrics, 2020, 46(1).

Ji Y P, Park S, Sun H L, et al. Microorganisms Causing Community-Acquired Acute Bronchitis: The Role of Bacterial Infection[J]. Plos One, 2016,11(10):e0165553.

Teo S, D Mok, Pham K, et al. The Infant Nasopharyngeal Microbiome Impacts Severity of Lower Respiratory Infection and Risk of Asthma Development[J]. Cell host & microbe, 2015,17(5):704-715

.

Mei T S, Tang H, Danny M, et al. Airway Microbiota Dynamics

Uncover a Critical Window for Interplay of Pathogenic Bacteria and Allergy in Childhood Respiratory Disease[J]. Cell host & microbe, 2018,24(3):341-352.

Self, Wesley, H, et al. Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia[J]. Clinical infectious diseases, 2018.

Korppi, Matti. Community-acquired pneumonia in children.[J]. Pediatric Drugs, 2003,5(12):821-832.

Dickson R P, Erb-Downward J R, Huffnagle G B. The role of the bacterial microbiome in lung disease[J]. Expert Rev Respir Med, 2013,7(3):245-257.

Marie R, Griffin, Yuwei, et al. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination[J]. The New England journal of medicine, 2013.

File J T, Low D, Eckburg P, et al. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia[J]. Clinical Infectious Diseases An Official Publication of the Infectious Diseases Society of America, 2010,51(12):1395-1405.

Schwarzmann, Stephen W. Bacterial Pneumonia During the Hong Kong Influenza Epidemic of 1968-1969: Experience in a City-County Hospital[J]. Archives of Internal Medicine, 1971,127(6):1037-1041.

Defres S, Marwick C, Nathwani D. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia[J]. The European respiratory journal, 2009,34(6):1470-1476.

Johnstone J, Majumdar S R, Fox J D, et al. Viral Infection in Adults Hospitalized With Community-Acquired Pneumonia: Prevalence, Pathogens, and Presentation[J]. Chest, 2008.

Lauer S A, Grantz K H, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application[J]. Annals of internal medicine, 2020,172(9).

Ehsan M, Metersky M L. Management of community-acquired pneumonia[J]. Current Respiratory Care Reports, 2013, 2(4):218-225.

Subbarao K, Mahanty S. Respiratory virus infections: Understanding COVID-19[J]. Immunity, 2020,52(6).

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v5i4.11691